Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aerovate Therapeutics
(AVTE) Q2 2025
Earnings
AVTE
May 14
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-12.1
-8.22
-4.34
-0.47
Details
Expected EPS
-6.025
Actual EPS
-12.1
Surprise EPS
-6.07
Surprise Percent
-100.83%
Description
Aerovate Therapeutics (AVTE) has reported earnings of -12.1 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login